• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染下调缺氧诱导因子1α表达以抑制肝癌的血管生成和肿瘤发生。

infection downregulates hypoxia‑inducible factor 1α expression to suppress the vascularization and tumorigenesis of liver cancer.

作者信息

Wu Runling, Chen Xiao, Chen Huan, Li Mei, Liang Yun

机构信息

Department of Geriatric Respiratory Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China.

Department of Medical Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China.

出版信息

Oncol Lett. 2024 Oct 14;28(6):604. doi: 10.3892/ol.2024.14737. eCollection 2024 Dec.

DOI:10.3892/ol.2024.14737
PMID:39483968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11525613/
Abstract

Liver cancer is characterized by hypervascularization. Anti-angiogenic agents may normalize the tumor vasculature and improve the efficacy of other treatments. The present study aims to investigate the anti-angiogenic effect of infection in a mouse model of implanted liver cancer cells. HepG2 cells were injected into the left liver lobe of nude mice as a model of hepatic tumorigenesis. parasitized erythrocytes were administered in the animal model of liver cancer to introduce infection. The tumor growth and microvascular density were determined in the presence or absence of infection. The expression levels of hypoxia-inducible factor 1α (HIF-1α) and angiogenesis-related factors were evaluated using western blotting and reverse transcription-quantitative PCR analysis. The results demonstrated that infection suppressed tumor growth and vascularization in the mouse model of implanted HepG2 cells. parasites reduced the expression of pro-angiogenic factors (vascular endothelial growth factor A and angiopoietin 2), matrix metalloproteinases [(MMP)2 and MMP9] and inflammatory cytokines [tumor necrosis factor α, interleukin 6 (IL)-6) and IL-1β] in both hepatic and tumor tissues. HIF-1α was downregulated in both hepatic and tumor tissues upon infection, and HIF-1α overexpression rescued angiogenesis and tumor growth under the condition of infection. In conclusion, the results of the present study demonstrated the anti-angiogenic and anti-tumorigenic effects of infection on liver cancer through downregulating HIF-1α expression, indicating that parasites could be developed as an intervention strategy to restrain neo-angiogenesis in liver cancer.

摘要

肝癌的特征是血管生成增加。抗血管生成药物可能会使肿瘤血管正常化,并提高其他治疗方法的疗效。本研究旨在探讨[感染名称]感染在植入肝癌细胞的小鼠模型中的抗血管生成作用。将HepG2细胞注射到裸鼠的左肝叶,作为肝肿瘤发生的模型。在肝癌动物模型中给予[寄生虫名称]寄生的红细胞以引入[感染名称]感染。在有或无[感染名称]感染的情况下测定肿瘤生长和微血管密度。使用蛋白质免疫印迹法和逆转录-定量PCR分析评估缺氧诱导因子1α(HIF-1α)和血管生成相关因子的表达水平。结果表明,[感染名称]感染抑制了植入HepG2细胞的小鼠模型中的肿瘤生长和血管生成。[寄生虫名称]寄生虫降低了肝脏和肿瘤组织中促血管生成因子(血管内皮生长因子A和血管生成素2)、基质金属蛋白酶[(MMP)2和MMP9]以及炎性细胞因子[肿瘤坏死因子α、白细胞介素6(IL)-6和IL-1β]的表达。[感染名称]感染后,肝脏和肿瘤组织中的HIF-1α均下调,并且在[感染名称]感染的条件下,HIF-1α过表达挽救了血管生成和肿瘤生长。总之,本研究结果证明了[感染名称]感染通过下调HIF-1α表达对肝癌具有抗血管生成和抗肿瘤作用,表明[寄生虫名称]寄生虫可被开发为一种抑制肝癌新生血管生成的干预策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cce/11525613/c7dc554a0b36/ol-28-06-14737-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cce/11525613/d187b070da81/ol-28-06-14737-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cce/11525613/f710ec30278c/ol-28-06-14737-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cce/11525613/127ce2f5ac9a/ol-28-06-14737-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cce/11525613/0d0cff22d5ea/ol-28-06-14737-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cce/11525613/c7dc554a0b36/ol-28-06-14737-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cce/11525613/d187b070da81/ol-28-06-14737-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cce/11525613/f710ec30278c/ol-28-06-14737-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cce/11525613/127ce2f5ac9a/ol-28-06-14737-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cce/11525613/0d0cff22d5ea/ol-28-06-14737-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cce/11525613/c7dc554a0b36/ol-28-06-14737-g04.jpg

相似文献

1
infection downregulates hypoxia‑inducible factor 1α expression to suppress the vascularization and tumorigenesis of liver cancer.感染下调缺氧诱导因子1α表达以抑制肝癌的血管生成和肿瘤发生。
Oncol Lett. 2024 Oct 14;28(6):604. doi: 10.3892/ol.2024.14737. eCollection 2024 Dec.
2
Effect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angiogenesis.结缔组织生长因子对缺氧诱导因子1α降解及肿瘤血管生成的影响。
J Natl Cancer Inst. 2006 Jul 19;98(14):984-95. doi: 10.1093/jnci/djj242.
3
Bone marrow-derived mesenchymal stem cells induced by inflammatory cytokines produce angiogenetic factors and promote prostate cancer growth.炎性细胞因子诱导的骨髓间充质干细胞产生血管生成因子并促进前列腺癌生长。
BMC Cancer. 2017 Dec 21;17(1):878. doi: 10.1186/s12885-017-3879-z.
4
HIF-1α regulated pathomechanism of low birth weight through angiogenesis factors in placental infection.低出生体重通过胎盘感染中血管生成因子的 HIF-1α 调节发病机制。
F1000Res. 2024 Jun 5;11:131. doi: 10.12688/f1000research.73820.3. eCollection 2022.
5
[Hypoxia-inducible factor-1α mediates and regulates angiogenesis-related factors expression in hepatocellular carcinoma].缺氧诱导因子-1α介导并调节肝细胞癌中血管生成相关因子的表达
Zhonghua Gan Zang Bing Za Zhi. 2020 Nov 20;28(11):942-948. doi: 10.3760/cma.j.cn501113-20200228-00074.
6
An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells.Akt/缺氧诱导因子-1α/血小板衍生生长因子-BB自分泌环介导肝癌细胞和致瘤性肝祖细胞中的缺氧诱导化疗耐药。
Clin Cancer Res. 2009 May 15;15(10):3462-71. doi: 10.1158/1078-0432.CCR-08-2127.
7
Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis.橄榄油产物二羟苯乙醇通过抑制低氧诱导因子-1α,阻断微粒体前列腺素 E 合酶-1/血管内皮生长因子表达,减少肿瘤血管生成。
Clin Cancer Res. 2010 Aug 15;16(16):4207-16. doi: 10.1158/1078-0432.CCR-10-0156. Epub 2010 Aug 3.
8
ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo.ENMD-1198,一种新型微管蛋白结合剂,可降低人肝癌(HCC)细胞中的缺氧诱导因子-1α(HIF-1α)和信号转导与转录激活因子3(STAT3)活性,并在体内抑制肿瘤生长和血管生成。
BMC Cancer. 2008 Jul 23;8:206. doi: 10.1186/1471-2407-8-206.
9
Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.缺氧诱导因子-1通过诱导多种血管生成因子来介导培养的血管内皮细胞的激活。
Circ Res. 2003 Oct 3;93(7):664-73. doi: 10.1161/01.RES.0000093984.48643.D7. Epub 2003 Sep 4.
10
Effects of the knockdown of hypoxia inducible factor-1α expression by adenovirus-mediated shRNA on angiogenesis and tumor growth in hepatocellular carcinoma cell lines.腺病毒介导的短发夹RNA敲低缺氧诱导因子-1α表达对肝癌细胞系血管生成和肿瘤生长的影响
Korean J Hepatol. 2010 Sep;16(3):280-7. doi: 10.3350/kjhep.2010.16.3.280.

引用本文的文献

1
HIF-1α: A Key Factor Mediating Tumor Cells from Digestive System to Evade NK Cell Killing via Activating Metalloproteinases to Hydrolyze MICA/B.缺氧诱导因子-1α:介导消化系统肿瘤细胞通过激活金属蛋白酶水解MICA/B以逃避自然杀伤细胞杀伤的关键因子
Biomolecules. 2025 Jun 19;15(6):899. doi: 10.3390/biom15060899.

本文引用的文献

1
Angiogenesis and Hepatocellular Carcinoma: From Molecular Mechanisms to Systemic Therapies.血管生成与肝细胞癌:从分子机制到系统治疗。
Medicina (Kaunas). 2023 Jun 9;59(6):1115. doi: 10.3390/medicina59061115.
2
Advances in experimental animal models of hepatocellular carcinoma.肝细胞癌实验动物模型的研究进展。
Cancer Med. 2023 Jul;12(14):15261-15276. doi: 10.1002/cam4.6163. Epub 2023 May 29.
3
The latest global burden of liver cancer: A past and present threat.最新的全球肝癌负担:过去与现在的威胁。
Clin Mol Hepatol. 2023 Apr;29(2):355-357. doi: 10.3350/cmh.2023.0070. Epub 2023 Mar 9.
4
Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace.细胞因子与肝细胞癌:致命关联的生物标志物
J Pers Med. 2022 Dec 20;13(1):5. doi: 10.3390/jpm13010005.
5
Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies.肝细胞癌中的血管生成:机制与抗血管生成治疗。
Cancer Biol Med. 2023 Jan 12;20(1):25-43. doi: 10.20892/j.issn.2095-3941.2022.0449.
6
Hepatocellular Carcinoma: New Developments.肝细胞癌:新进展。
Clin Liver Dis. 2023 Feb;27(1):85-102. doi: 10.1016/j.cld.2022.08.004. Epub 2022 Oct 18.
7
Hepatocellular Carcinoma.肝细胞癌。
Crit Care Nurs Clin North Am. 2022 Sep;34(3):289-301. doi: 10.1016/j.cnc.2022.04.004. Epub 2022 Jul 20.
8
Anti-Tumor Effect of Parasitic Protozoans.寄生原生动物的抗肿瘤作用
Bioengineering (Basel). 2022 Aug 16;9(8):395. doi: 10.3390/bioengineering9080395.
9
Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application.肝细胞癌的小鼠模型:分类、进展与应用
Front Oncol. 2022 Jun 30;12:902820. doi: 10.3389/fonc.2022.902820. eCollection 2022.
10
Risk Score Model for Microvascular Invasion in Hepatocellular Carcinoma: The Role of Tumor Burden and Alpha-Fetoprotein.肝细胞癌微血管侵犯的风险评分模型:肿瘤负荷和甲胎蛋白的作用
Cancers (Basel). 2021 Aug 31;13(17):4403. doi: 10.3390/cancers13174403.